ASH 2009: Heinz Ludwig
Bortezomib-Doxorubicin-Dexamethasone (BDD) in Patients with Acute Light Chain Induced Renal Failure (ARF) in Multiple Myeloma (MM). Final Results of a Phase II Study
Heinz Ludwig, MD
Center for Oncology and Hematology
Wilhelminenspital
Vienna, Austria
12.18.09
Ludwig 3862
To view the video full screen, click on the small
button next to the volume control in the
lower right hand corner.
button next to the volume control in the
lower right hand corner.
print
related articles